SHREWSBURY STEPHEN B 4
4 · IMPEL NEUROPHARMA INC · Filed Mar 30, 2022
Insider Transaction Report
Form 4
SHREWSBURY STEPHEN B
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-29$1.97/sh+24,606$48,474→ 97,990 total - Exercise/Conversion
Stock Option (right to buy)
2022-03-29−24,606→ 0 totalExercise: $1.97Exp: 2027-02-13→ Common Stock (24,606 underlying)
Footnotes (1)
- [F1]The option is 100% vested and exercisable.